2026 NPPES data Otolaryngology/Facial Plastic Surgery Physician NPI 1598083024 M.D.
Verify on CMS →

MARK TOMA, M.D.

Otolaryngology/Facial Plastic Surgery Physician in DEARBORN, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
962
Medicare Part D claims · 312 beneficiaries · Otolaryngology/Facial Plastic Surgery Physician avg: 561
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
32.6486/100
▼ 50 pts below national avg 83.1 · [object Object]
Industry payments
$390.67
7 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK TOMA, M.D. reported a CMS MIPS final score of 32.6486/100 — below the 83.1 national average — and filed 962 Medicare Part D claims in 2023.

32.6486/100
MIPS score · -50 vs avg
962
Part D claims, 2023
95%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK TOMA, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

33 3rd percentile higher than 3% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). This entry sits in this band. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARK TOMA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK TOMA, M.D.?

Below national average

NPI registry status

Active

Issued 05/07/2010

NPI 1598083024

Primary specialty

Otolaryngology/Facial Plastic Surgery Physician

Niche

744 US NPIs in this specialty

Medicare Part D claims

962 71% vs specialty avg

2023 prescription claims

Specialty avg: 561

MIPS final score

32.6486/100 50.45139999999999% pts

Below average band

vs 83.1 national avg

Specialty distribution in Michigan

How Otolaryngology/Facial Plastic Surgery Physician compares to other specialties among Michigan providers

Michigan providers

Otolaryngology/Facial Plastic Surgery Physician share within Michigan

1. Otolaryngology/Facial Plastic Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Otolaryngology/Facial Plastic Surgery Physician share within Michigan

Medicare quality performance — MIPS

MARK TOMA, M.D.'s 2023 MIPS final score plotted against the Otolaryngology/Facial Plastic Surgery Physician national average

Below national average
MIPS Final Score
32.6486/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Otolaryngology/Facial Plastic Surgery Physician) — 32.6486/100 vs national avg 83.1

0%100%National avg83%32.6%
MIPS final score (Otolaryngology/Facial Plastic Surgery Physician) — 32.6486/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK TOMA, M.D. appears in the CMS NPPES registry as a Otolaryngology/Facial Plastic Surgery Physician provider holding M.D. credentials at 2421 MONROE ST, DEARBORN, MI, 48124, with a listed phone of (313) 562-4100. NPI 1598083024 was issued on 05/07/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TOMA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 962 prescription claims written by this provider, covering 312 Medicare beneficiaries and totaling roughly $33K in drug spend, split 5% brand-name and 95% generic by claim count, with an opioid prescribing rate of 3.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 32.6486/100 for the 2023 performance year (Quality 55.9967), compared with the national average of 83.1.

Otolaryngology/Facial Plastic Surgery Physician is a narrow specialty nationwide, with 744 enrolled providers across 53 states and an average of 561 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2421 MONROE ST
DEARBORN, MI 48124

Provider Details

NPI 1598083024
Specialty Otolaryngology/Facial Plastic Surgery Physician
Credentials M.D.
Gender Male
NPI Issued 05/07/2010

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

32.6486
Final Score
Avg: 83.1
55.9967
Quality

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARK TOMA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

DANNY KEWSON M.D. P.C
DEARBORN, MI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK TOMA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$391

Largest payer

Medtronic, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Michigan MI-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to MARK TOMA, M.D.. To verify MARK TOMA, M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MARK TOMA, M.D. — brand share 5.0%
Specialty average (est.)

5% brand-name claims vs 95% generic, on 962 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

962
Total Claims
$33K
Total Drug Cost
312
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,587
Total Day Supply
40,426
Brand vs Generic
5% brand / 95% generic
Brand Drug Cost
$5K
Generic Drug Cost
$27K
Opioid Claims
34 (3.5% rate)
Antibiotic Claims
153

Patient Demographics

Average Patient Age
69.6 years
Avg HCC Risk Score
1.42
Gender Split
68% female / 32% male
Age Distribution
<65: 61, 65-74: 153, 75-84: 85, 85+: 13

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK TOMA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Fluticasone Propionate
196
Azelastine Hcl
168
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
82
Mupirocin
62
Montelukast Sodium
60
Ipratropium Bromide
44
Omeprazole
44
Famotidine
43
Nystatin
35
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
31

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Otolaryngology/Facial Plastic Surgery Physician Overview

How MARK TOMA, M.D. fits within the Otolaryngology/Facial Plastic Surgery Physician landscape nationally.

744
Otolaryngology/Facial Plastic Surgery Physician Providers in US
53
States with Otolaryngology/Facial Plastic Surgery Physician
561
Avg Claims per Provider

MARK TOMA, M.D.'s 962 claims are above the specialty average of 561.

Nearby Otolaryngology/Facial Plastic Surgery Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as TOMA.

Compare Otolaryngology/Facial Plastic Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK TOMA, M.D.'s specialty?
MARK TOMA, M.D. specializes in Otolaryngology/Facial Plastic Surgery Physician and practices in DEARBORN, Michigan. Credentials: M.D..
How much does MARK TOMA, M.D. prescribe under Medicare Part D?
In 2023, MARK TOMA, M.D. wrote 962 Medicare Part D claims totaling $33K in drug costs for 312 beneficiaries.
What is MARK TOMA, M.D.'s Medicare quality score?
MARK TOMA, M.D. has a CMS MIPS Final Score of 32.6486/100 (Quality: 55.9967). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK TOMA, M.D. located?
MARK TOMA, M.D. is located at 2421 MONROE ST, DEARBORN, MI, 48124. Phone: (313) 562-4100.
What is MARK TOMA, M.D.'s NPI number?
MARK TOMA, M.D.'s National Provider Identifier (NPI) is 1598083024, issued on 05/07/2010.
Does MARK TOMA, M.D. prescribe more brand-name or generic drugs?
MARK TOMA, M.D.'s prescribing is 5% brand-name and 95% generic drugs by claim count, with $5K in brand drug costs.
Does MARK TOMA, M.D. prescribe opioids?
Yes, MARK TOMA, M.D. had 34 opioid claims in 2023 with an opioid prescribing rate of 3.5%.
How many Otolaryngology/Facial Plastic Surgery Physician providers are there in the US?
There are 744 Otolaryngology/Facial Plastic Surgery Physician providers across 53 states in the US. The average Otolaryngology/Facial Plastic Surgery Physician provider writes 561 Medicare Part D claims per year.
What drugs does MARK TOMA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK TOMA, M.D.'s most frequently prescribed drugs include Fluticasone Propionate, Azelastine Hcl, Amoxicillin-Clavulanate Potass. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK TOMA, M.D. accept Medicare?
MARK TOMA, M.D. appears in CMS Medicare data with 962 Part D claims and 312 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK TOMA, M.D.'s credentials?
MARK TOMA, M.D.'s NPI is 1598083024 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology